Amgen / 安进

Amgen / 安进 appears in 130. 谁才是生物医药行业发展的核心驱动力？兼谈创新药产业链的角色分工 as a BioPharm company that the speakers treat as closer to an MNC than many biotech firms. Its role in the source is comparative: Amgen helps separate mature BioPharm capability from the even broader global portfolio and commercialization reach of century-scale multinational pharma.

Connections

• BioTech To BioPharm Transition - maturity path from small biotech to BioPharm.
• Global Pharma Commercialization - MNC comparison point.
• First-In-Class Drug Discovery Role Split - large-company development and launch side.